LobbyingDermatology Association of Radiation Therapy lobbying by quarter
Dermatology Association of Radiation Therapy's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $280K. Its first report covers Q1 2025; the issues it reports most are Medicare/Medicaid and Medical/Disease Research/Clinical Labs.
Dermatology Association of Radiation Therapy
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $280K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2025 | $30K | 1 |
| Q2 2025 | $80K | 2 |
| Q3 2025 | $150K | 2 |
| Q4 2025 | $140K | 2 |
| Q1 2026 | $110K | 2 |
| Q2 2026 | $30K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$400K · 11 reports
- Medical research and clinical labs$140K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES8 reports
- SENATE6 reports
- Centers For Medicare and Medicaid Services (CMS)3 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseDermatology Association of Radiation Therapy | $280K | 5 quarters |
| Holland & Knight | $260K | 6 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/12for Q2 | Holland & Knight | $10K |
| 07/08for Q2 | In-house | $20K |
| 04/20for Q1 | In-house | $60K |
| 04/04for Q1 | Holland & Knight | $50K |
| 01/20for Q4 2025 | In-house | $80K |
| 01/11for Q4 2025 | Holland & Knight | $60K |
| 25/10/20for Q3 2025 | In-house | $90K |
| 25/10/11for Q3 2025 | Holland & Knight | $60K |
| 25/07/21for Q2 2025 | In-house | $30K |
| 25/07/11for Q2 2025 | In-house | Under $5,000 |
| 25/07/06for Q2 2025 | Holland & Knight | $50K |
| 25/04/11for Q1 2025 | Holland & Knight | $30K |
| 25/03/21for Q1 2025 | Holland & Knight | Under $5,000 |